BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29128848)

  • 1. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
    Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo properties of ellagic acid in malaria treatment.
    Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
    Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
    Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M
    Malar J; 2009 Apr; 8():79. PubMed ID: 19389221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
    Tahar R; Vivas L; Basco L; Thompson E; Ibrahim H; Boyer J; Nepveu F
    J Antimicrob Chemother; 2011 Nov; 66(11):2566-72. PubMed ID: 21862474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana.
    Aniweh Y; Soulama A; Chirawurah J; Ansah F; Danwonno HA; Sogore F; Rouillier M; Campo B; Amenga-Etego L; Djimde AA; Awandare GA; Dembele L
    Microbiol Spectr; 2023 Jun; 11(3):e0491622. PubMed ID: 37093000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.
    Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA
    Malar J; 2013 Dec; 12():450. PubMed ID: 24341604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.
    Kwansa-Bentum B; Ayi I; Suzuki T; Otchere J; Kumagai T; Anyan WK; Osei JH; Asahi H; Ofori MF; Akao N; Wilson MD; Boakye DA; Ohta N
    Malar J; 2011 Jul; 10():187. PubMed ID: 21745377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
    de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
    Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
    Quashie NB; Duah NO; Abuaku B; Koram KA
    Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
    Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
    Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Surveillance and in vitro Drug Sensitivity Study of
    Wang S; Xu S; Geng J; Si Y; Zhao H; Li X; Yang Q; Zeng W; Xiang Z; Chen X; Zhang Y; Li C; Kyaw MP; Cui L; Yang Z
    Am J Trop Med Hyg; 2020 Sep; 103(3):1100-1106. PubMed ID: 32588794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.